Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.12M Sell
39,200
-156,800
-80% -$18.4M ﹤0.01% 3903
2025
Q4
$24.5M Sell
196,000
-84,300
-30% -$10M ﹤0.01% 2194
2025
Q3
$33.6M Buy
+280,300
New +$29.6M ﹤0.01% 1766
2025
Q2
Sell
-701,000
Closed -$61.7M 6121
2025
Q1
$61.7M Sell
701,000
-851,600
-55% -$83.7M 0.01% 1090
2024
Q4
$144M Buy
+1,552,600
New +$149M 0.02% 635
2024
Q3
Sell
-555,000
Closed -$41.6M 5857
2024
Q2
$41.6M Buy
+555,000
New +$44.3M 0.01% 1295
2023
Q4
Sell
-25,000
Closed -$1.37M 5654
2023
Q3
$1.37M Buy
+25,000
New +$1.42M ﹤0.01% 4049

Other funds holding CRH

Goldman Sachs's CRH Position: Q1 2026 in Review

Goldman Sachs increased its CRH (CRH) stake by 9% in Q1 2026, buying an estimated $66.7M and bringing the position to 6,890,634 shares worth $724M. The position accounts for 0.08% of the portfolio, ranked #239.

Goldman Sachs first reported a position in CRH in Q2 2013 and has held it in 52 quarters since. The position peaked at $821M in Q3 2025. 1,006 funds tracked by Wall St. Rank hold CRH as of Q1 2026.

  • Goldman Sachs held 6,890,634 shares of CRH worth $724M as of Q1 2026.
  • Goldman Sachs bought 567,803 CRH shares in Q1 2026, an estimated $66.7M.
  • CRH made up 0.08% of Goldman Sachs's portfolio in Q1 2026, its #239 holding.
  • Goldman Sachs first reported a position in CRH in Q2 2013 and has held it in 52 quarters since.
  • Goldman Sachs's CRH position peaked at $821M in Q3 2025.
  • 1,006 funds tracked by Wall St. Rank held CRH as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.